Iwasaki A, Suda M, Nakao H, Nagoya T, Saino Y, Arai K, Mizoguchi T, Sato F, Yoshizaki H, Hirata M
Department of Cell Biology, Kowa Research Institute, Ibaraki.
J Biochem. 1987 Nov;102(5):1261-73. doi: 10.1093/oxfordjournals.jbchem.a122165.
An inhibitor of blood coagulation, a new protein with an apparent molecular weight of 34,000 and an isoelectric point of 4.9, was purified from human placental tissue by EDTA extraction. Five cDNA clones were isolated from the human placental lambda gt11 cDNA library using the mouse monoclonal antibody raised against the coagulation inhibitor as the probe. The longest insert consists of 1,566 nucleotides, and contains 960 nucleotides entirely encoding the 320 amino acids of the inhibitor, and a poly A tail. The deduced amino acid sequence was corroborated by chemical analyses of the protein. The entire amino acid sequence shows homology to those of lipocortin I, lipocortin II, and endonexin-related proteins. The cDNA for the inhibitor was expressed in Escherichia coli under the regulation of the trc promotor of the plasmid pKK233-2. The resulting recombinant protein manifested inhibitory activities against both blood coagulation and phospholipase A2 activity, as did the coagulation inhibitor isolated from human placenta.
一种血液凝固抑制剂,一种表观分子量为34,000且等电点为4.9的新蛋白质,通过EDTA提取从人胎盘组织中纯化得到。使用针对该凝血抑制剂产生的小鼠单克隆抗体作为探针,从人胎盘λgt11 cDNA文库中分离出五个cDNA克隆。最长的插入片段由1566个核苷酸组成,包含960个完全编码该抑制剂320个氨基酸的核苷酸以及一个聚腺苷酸尾。推导的氨基酸序列通过该蛋白质的化学分析得到证实。整个氨基酸序列与脂皮质素I、脂皮质素II和内毒素相关蛋白的氨基酸序列具有同源性。该抑制剂的cDNA在质粒pKK233 - 2的trc启动子调控下在大肠杆菌中表达。所得重组蛋白表现出对血液凝固和磷脂酶A2活性的抑制活性,从人胎盘中分离出的凝血抑制剂也有此活性。